Ephrin-B2 signaling pathway

The **Ephrin-B2 signaling pathway** refers to the molecular communication system primarily involving Ephrin-B2 (a transmembrane ligand) and its receptor EphB4 (a receptor tyrosine kinase) on adjacent cells. This pathway mediates bidirectional signaling: "forward" signaling in the EphB4-expressing cell and "reverse" signaling in the ephrin-B2-expressing cell. Ephrin-B2 is essential for arterial specification, vascular development (angiogenesis and arteriovenous patterning), and diverse cellular interactions in both development and disease (especially in cancer, where it regulates tumor angiogenesis, growth, and therapy resistance)[1][3][4][5]. It influences cellular processes such as adhesion, migration, proliferation, and differentiation, with roles in both the nervous and vascular systems. In pathology, aberrant Ephrin-B2/EphB4 signaling is implicated in multiple cancers, treatment resistance, and vascular disorders, making it a relevant **therapeutic target** for antiangiogenic and tumor microenvironment-modulating strategies. Direct pharmacological agents targeting Ephrin-B2 or EphB4 are under investigation, and the pathway's complexity presents both therapeutic opportunities and safety challenges due to its vital role in normal tissue homeostasis and development[4][5].

Other names

EphrinB2 pathwayEphB4–ephrinB2 signalingEphrinB2–EphB4 axis

Inhibition or activation of EphB4 forward signaling. Stimulation or inhibition of ephrin-B2 reverse signaling. Modulation of downstream signaling pathways (e.g., ERK1/2, PI3K, Notch). Modulation of cell adhesion, migration, proliferation, and differentiation via ligand-receptor clustering.